Virtus Investment Advisers’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
11,884
+7,601
+177% +$920K 0.3% 164
2026
Q1
$700K Buy
4,283
+815
+24% +$125K 0.19% 177
2025
Q4
$604K Sell
3,468
-1,119
-24% -$204K 0.16% 218
2025
Q3
$661K Hold
4,587
0.19% 178
2025
Q2
$462K Sell
4,587
-399
-8% -$30.5K 0.16% 191
2025
Q1
$380K Buy
+4,986
New +$381K 0.1% 216
2023
Q2
Sell
-10,007
Closed -$171K 278
2023
Q1
$171K Sell
10,007
-10,385
-51% -$202K 0.12% 204
2022
Q4
$407K Hold
20,392
0.27% 116
2022
Q3
$439K Buy
+20,392
New +$489K 0.2% 97

Other funds holding INSM

Virtus Investment Advisers's INSM Position: Q2 2026 in Review

Virtus Investment Advisers increased its Insmed (INSM) stake by 177% in Q2 2026, buying an estimated $920K and bringing the position to 11,884 shares worth $1.27M. The position accounts for 0.3% of the portfolio, ranked #164.

Virtus Investment Advisers first reported a position in INSM in Q3 2022 and has held it in 9 quarters since. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Virtus Investment Advisers held 11,884 shares of Insmed worth $1.27M as of Q2 2026.
  • Virtus Investment Advisers bought 7,601 Insmed shares in Q2 2026, an estimated $920K.
  • Insmed made up 0.3% of Virtus Investment Advisers's portfolio in Q2 2026, its #164 holding.
  • Virtus Investment Advisers first reported a position in Insmed in Q3 2022 and has held it in 9 quarters since.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.